3HIW
C2X: 9,9'-{(2R,3R,3aR,5S,7aR,9R,10R,10aR,12S,23R,25aR,27R,28R,28aR,30S,32aR,35aR,37S,39aR)-9-(6-amino-9H-purin-9-yl)-34-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-5,12,23,30,37-pentahydroxy-3,10,28-trimethoxy-5,12,23,30,37-pentaoxidotetracosahydro-2H,7H,25H-trifuro[3,2-f:3',2'-l:3'',2''-x]pyrrolo[3,4-r][1,3,5,9,11,15,17,21,23,27,29,2,4,10,16,22,28]undecaoxazapentaphosphacyclopentatriacontine-2,27-diyl}bis(2-amino-3,9-dihydro-6H-purin-6-one)
C2X is a Ligand Of Interest in 3HIW designated by the RCSB
Best-fitted instance in this entry | |
Other instances in this entry |
Best-fitted instance in this entry | |
Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3HIW_C2X_B_260 | 16% | 42% | 0.251 | 0.819 | 0.88 | 1.37 | 4 | 11 | 53 | 0 | 100% | 1 |
3HIW_C2X_A_260 | 11% | 41% | 0.266 | 0.79 | 0.88 | 1.41 | 3 | 10 | 56 | 0 | 100% | 1 |
3HIO_C2X_A_268 | 6% | 28% | 0.294 | 0.717 | 0.93 | 1.91 | 4 | 14 | 51 | 0 | 100% | 0.7 |